BCAX financials

Bicara Therapeutics (BCAX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

BCAX income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$155.60M-$137.95M-2.52
2024––-$82.39M-$68.00M-4.05
2023––-$39.89M-$51.98M-89.61